Federal Circuit Vacates PTAB’s Denial of Motion to Amend

Sep 2, 2016

Reading Time : 2 min

In April 2014, the PTAB instituted inter partes review of U.S. Patent No. 7,024,527 (the “’527 patent”), which is directed to processes for restoring computer data. The petitioner, Veeam Software Corp. (“Veeam”), challenged the patentability of Veritas’s patent based on prior art that disclosed block-level restoration processes. Veritas, however, argued that the challenged claims did not encompass such processes and were more narrowly limited to file-level background restoration processes. Veritas also filed a contingent motion to amend the claims if the PTAB ultimately found the challenged claims to be unpatentable. Veritas’s claim amendments sought to expressly limit the claims to file-level background restoration processes.

In its April 2015 final written decision, the PTAB construed the challenged claims to encompass block-level restoration processes and rejected all of the challenged claims as obvious in view of the prior art. The PTAB also denied Veritas’s contingent motion to amend, ruling that its motion was deficient for failure to discuss how Veritas’s claim amendments would render the claims patentable over the prior art. Specifically, the PTAB explained that Veritas “offer[ed] no discussion of whether the newly added features” in its claim amendments were “separately known in the art.” Instead, according to the PTAB, Veritas only discussed how “the newly added feature[s] in combination with other known features [were] not in the prior art.”

On appeal, the Federal Circuit affirmed the PTAB’s obviousness determination, but held that the PTAB erred in denying Veritas’s motion to amend. The Federal Circuit stated that the PTAB’s basis for denying the motion to amend was “unreasonable and hence must be set aside as arbitrary and capricious.” The court explained that it had “been shown no reason to doubt that it is only the combination that was the ‘new feature,’ a scenario recognized in a long line of Supreme Court and Federal Circuit cases noting that novel and nonobvious inventions often are only a combination of known individual features.” The court further noted that it failed “to see how describing the combination is meaningfully different from describing what is new about the proposed claims, even in comparison to the unamended claims.” Therefore, the Federal Circuit “d[id] not see how the Board could reasonably demand more from Veritas in this case”  and vacated and remanded the case for a determination of the patentability of the proposed amended claims.

Notably, the Federal Circuit rendered its opinion “independently of any resolution of [the] [C]ourt’s recently initiated en banc proceeding in In re Aqua Products.”

Veritas Techs. LLC v. Veeam Software Corp., No. 2015-1894 (Fed. Cir. Aug. 30, 2016)”

Share This Insight

Previous Entries

IP Newsflash

July 22, 2026

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed its claim there before it filed a parallel suit in a district court and because it adequately pleaded the government’s involvement.

...

Read More

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.